Our data suggest that PT has the potential to regulate insulin resistance and metabolic syndrome by lowering the mRNA expression of PDPK-1, CCR4, CCR6, and CCL4L2 in PBMCs. This evidence concerns the gene CCR4 and metabolic syndrome.